Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Total Current Assets: €4.51 Mil (As of Dec. 2025)


MIL:ERFO Laboratorio Farmaceutico Erfo SpA MIL:ERFO
67 GF Score
Price €1.17
GF Value €2.11
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Laboratorio Farmaceutico Erfo SpA Total Current Assets?

Laboratorio Farmaceutico Erfo SpA MIL:ERFO +1.30% 67 Total Current Assets is €4.51 Mil as of Dec. 2025. GuruFocus rates MIL:ERFO with a GF Score™ of 67/100 and a GF Value™ of €2.11 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Laboratorio Farmaceutico Erfo SpA's total current assets for the quarter that ended in Dec. 2025 was €4.51 Mil.


Laboratorio Farmaceutico Erfo SpA  (MIL:ERFO) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Laboratorio Farmaceutico Erfo SpA's Liquidation Value for the quarter that ended in Dec. 2025 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1.054-3.665+0.75 * 1.119+0.5 * 1.378
=-1.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Farmaceutico Erfo SpA Total Current Assets Related Terms


Laboratorio Farmaceutico Erfo SpA Total Current Assets Historical Data

* Premium members only.

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorio Farmaceutico Erfo SpA Total Current Assets Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Assets
Get a 7-Day Free Trial 1.57 2.38 3.29 2.56 4.51

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.29 3.99 2.56 4.42 4.51
MIL:ERFO
67GF Score
Laboratorio Farmaceutico Erfo SpA MIL:ERFO
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorio Farmaceutico Erfo SpA Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Laboratorio Farmaceutico Erfo SpA's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Laboratorio Farmaceutico Erfo SpA's Total Current Assets for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of €4.51 Mil mean?
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a Total Current Assets of €4.51 Mil as of Dec. 2025. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Laboratorio Farmaceutico Erfo SpA and its competitors.
Is Laboratorio Farmaceutico Erfo SpA's Total Current Assets too high?
Laboratorio Farmaceutico Erfo SpA's current Total Current Assets is €4.51 Mil. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Farmaceutico Erfo SpA's Total Current Assets compare to KHC and GIS?
Laboratorio Farmaceutico Erfo SpA's Total Current Assets of €4.51 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Consumer Packaged Goods company?
A good Total Current Assets depends on the Consumer Packaged Goods industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Laboratorio Farmaceutico Erfo SpA and its competitors. Laboratorio Farmaceutico Erfo SpA's current Total Current Assets is €4.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.11, compared to a current price of €1.17 — trading 44.8% below its estimated fair value. The current Total Current Assets is €4.51 Mil. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current Total Current Assets is €4.51 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued. The current stock price of €1.17 is trading 44.8% below its estimated GF Value™ of €2.11. GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.

Key valuation signals for MIL:ERFO:

  • Total Current Assets: €4.51 Mil
  • GF Value™: €2.11 vs. price of €1.17 (44.8% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Laboratorio Farmaceutico Erfo SpA Business Description

Address Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
67GF Score

Get the complete analysis for MIL:ERFO

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.17
Price
€2.11
GF Value